Immune checkpoint protein VISTA can directly turn off T-cells during immunotherapy, study finds

FHS
May 17, 2024
6:23 pm

A Cleveland Clinic-led team of scientists and physicians have discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment.

New Tricuspid Interventions Launched into ‘Broken’ System

NEW YORK CITY — Recent device approvals officially put transcatheter tricuspid valve intervention (TTVI) on the map for symptomatic severe tricuspid regurgitation (TR), though workforce

June 9, 2024

Surgalign files for bankruptcy, agrees to sell US hardware unit for $5M

Dive Brief: Surgalign has filed for bankruptcy and agreed to sell its U.S. hardware and biomaterials assets to Xtant Medical Holdings for $5 million. After

June 21, 2023

Public pharma is the best solution to the ongoing problem of drug shortages

Drug shortages in the United States are at a record high. At least 14 essential generic cancer drugs are currently in shortage, forcing patients and

August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.